Lilly Expands AI Ties to Insilico, from Customer to Drug Discovery Partner

Eli Lilly will partner with Insilico Medicine on an artificial intelligence (AI)-based drug development collaboration that they said could generate “over $100 million” for the AI drug discovery company.